Literature DB >> 25738999

Metabolic control of cancer cell stemness: Lessons from iPS cells.

Javier A Menendez1,2.   

Abstract

The Nobel prized discovery of nuclear reprogramming is swiftly providing mechanistic evidence of a role for metabolism in the generation of cancer stem cells (CSC). Traditionally, the metabolic demands of tumors have been viewed as drivers of the genetic programming detected in cancer tissues. Beyond the energetic requirements of specific cancer cell states, it is increasingly recognized that metabolism per se controls epi-transcriptional networks to dictate cancer cell fate, i.e., metabolism can define CSC. Here I review the CSC-related metabolic features found in induced pluripotent stem (iPS) cells to provide an easily understandable framework in which the infrastructure and functioning of cellular metabolism might control the efficiency and kinetics of reprogramming in the re-routing of non-CSC to CSC-like cellular states. I suggest exploring how metabolism-dependent regulation of epigenetics can play a role in directing CSC states beyond conventional energetic demands of stage-specific cancer cell states, opening a new dimension of cancer in which the "physiological state" of CSC might be governed not only by cell-autonomous cues but also by local micro-environmental and systemic metabolo-epigenetic interactions. Forthcoming studies should decipher how specific metabolites integrate and mediate the overlap between the CSC-intrinsic "micro-epigenetics" and the "upstream" local and systemic "macro-epigenetics," thus paving the way for targeted epigenetic regulation of CSCs through metabolic modulation including "smart foods" or systemic "metabolic nichotherapies."

Entities:  

Keywords:  Waddington; cancer stem cells; epigenetic landscapes; metabolism; reprogramming; stemness

Mesh:

Year:  2015        PMID: 25738999      PMCID: PMC4825763          DOI: 10.1080/15384101.2015.1022697

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  143 in total

Review 1.  Potential applications for biguanides in oncology.

Authors:  Michael Pollak
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

3.  Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells.

Authors:  Alessandro Prigione; James Adjaye
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

4.  Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.

Authors:  Clifford D L Folmes; Timothy J Nelson; Almudena Martinez-Fernandez; D Kent Arrell; Jelena Zlatkovic Lindor; Petras P Dzeja; Yasuhiro Ikeda; Carmen Perez-Terzic; Andre Terzic
Journal:  Cell Metab       Date:  2011-08-03       Impact factor: 27.287

5.  Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma.

Authors:  Tina Cascone; Matthew H Herynk; Li Xu; Zhiqiang Du; Humam Kadara; Monique B Nilsson; Carol J Oborn; Yun-Yong Park; Baruch Erez; Jörg J Jacoby; Ju-Seog Lee; Heather Y Lin; Fortunato Ciardiello; Roy S Herbst; Robert R Langley; John V Heymach
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

6.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

Review 7.  Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors.

Authors:  María Sánchez-Aragó; Laura Formentini; José M Cuezva
Journal:  Antioxid Redox Signal       Date:  2012-09-24       Impact factor: 8.401

8.  Metabolic oxidation regulates embryonic stem cell differentiation.

Authors:  Oscar Yanes; Julie Clark; Diana M Wong; Gary J Patti; Antonio Sánchez-Ruiz; H Paul Benton; Sunia A Trauger; Caroline Desponts; Sheng Ding; Gary Siuzdak
Journal:  Nat Chem Biol       Date:  2010-05-02       Impact factor: 15.040

9.  A small molecule that induces reactive oxygen species via cellular glutathione depletion.

Authors:  Tatsuro Kawamura; Yasumitsu Kondoh; Makoto Muroi; Makoto Kawatani; Hiroyuki Osada
Journal:  Biochem J       Date:  2014-10-01       Impact factor: 3.857

10.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Authors:  Wei Xu; Hui Yang; Ying Liu; Ying Yang; Ping Wang; Se-Hee Kim; Shinsuke Ito; Chen Yang; Pu Wang; Meng-Tao Xiao; Li-xia Liu; Wen-qing Jiang; Jing Liu; Jin-ye Zhang; Bin Wang; Stephen Frye; Yi Zhang; Yan-hui Xu; Qun-ying Lei; Kun-Liang Guan; Shi-min Zhao; Yue Xiong
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 38.585

View more
  20 in total

Review 1.  Mitostemness.

Authors:  Elisabet Cuyàs; Sara Verdura; Núria Folguera-Blasco; Cristian Bastidas-Velez; Ángel G Martin; Tomás Alarcón; Javier A Menendez
Journal:  Cell Cycle       Date:  2018-07-02       Impact factor: 4.534

2.  Metformin targets histone acetylation in cancer-prone epithelial cells.

Authors:  Elisabet Cuyàs; Salvador Fernández-Arroyo; Jorge Joven; Javier A Menendez
Journal:  Cell Cycle       Date:  2016-10-28       Impact factor: 4.534

Review 3.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

Review 4.  Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.

Authors:  Zhaoshi Bao; Yongzhi Wang; Qiangwei Wang; Shengyu Fang; Xia Shan; Jiguang Wang; Tao Jiang
Journal:  Front Med       Date:  2021-04-24       Impact factor: 4.592

5.  Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Authors:  Bruna Corominas-Faja; Luciano Vellon; Elisabet Cuyàs; Maria Buxó; Begoña Martin-Castillo; Dolors Serra; Jordi García; Ruth Lupu; Javier A Menendez
Journal:  Histol Histopathol       Date:  2016-10-07       Impact factor: 2.303

6.  Activation of the methylation cycle in cells reprogrammed into a stem cell-like state.

Authors:  Salvador Fernández-Arroyo; Elisabet Cuyàs; Joaquim Bosch-Barrera; Tomás Alarcón; Jorge Joven; Javier A Menendez
Journal:  Oncoscience       Date:  2016-01-05

7.  Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.

Authors:  Hengqiang Zhao; Qingke Duan; Zhengle Zhang; Hehe Li; Heshui Wu; Qiang Shen; Chunyou Wang; Tao Yin
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

8.  Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate.

Authors:  Alejandro Vazquez-Martin; Chris Van den Haute; Sílvia Cufí; Bruna Corominas-Faja; Elisabet Cuyàs; Eugeni Lopez-Bonet; Esther Rodriguez-Gallego; Salvador Fernández-Arroyo; Jorge Joven; Veerle Baekelandt; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2016-07       Impact factor: 5.682

9.  Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity.

Authors:  Elisabet Cuyàs; Sara Verdura; Salvador Fernández-Arroyo; Joaquim Bosch-Barrera; Begoña Martin-Castillo; Jorge Joven; Javier A Menendez
Journal:  Oncotarget       Date:  2017-10-15

Review 10.  Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells.

Authors:  Prajna Paramita Naik; Swagatika Panigrahi; Ratnakar Parida; Prakash Priyadarshi Praharaj; Chandra Sekhar Bhol; Shankargouda Patil; Nml Manjunath; Dipanjan Ghosh; Samir Kumar Patra; Sujit Kumar Bhutia
Journal:  Stem Cell Rev Rep       Date:  2021-08-05       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.